BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3223828)

  • 41. Upper gastrointestinal functions in progressive systemic sclerosis (PSS).
    Deodhar SD; Tyagi SK; Nath IV; Dilawari JB
    J Assoc Physicians India; 1982 Jun; 30(6):365-7. PubMed ID: 7169452
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC; Hasler WL; Owyang C
    N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcosis in generalized scleroderma.
    Nielsen AO; Brun B; Secher L
    Acta Derm Venereol; 1980; 60(4):301-7. PubMed ID: 6163274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The child with peptic esophagitis: a correlation of radiologic signs with esophageal pathology.
    Darling DB; McCauley RG; Leape LL; Ramenofsky ML; Bhan I; Leonidas JC
    Radiology; 1982 Dec; 145(3):673-6. PubMed ID: 7146395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Digestive complications in progressive systemic sclerosis].
    García de Castro J; Ledro D; Rubio E; Sánchez S; Benítez A; Garrido M
    Rev Esp Enferm Apar Dig; 1985 Nov; 68(5):425-7. PubMed ID: 4081268
    [No Abstract]   [Full Text] [Related]  

  • 46. [Round table: Scleroderma and esophageal changes].
    Abbati A; Andrieri D; Ballardini G; Bassi F; Bersani G; Bianchi FB; Bortolotti M; Bragaglia RB; Brusori S; De Vito M
    G Ital Dermatol Venereol; 1984; 119(4):233-61. PubMed ID: 6490098
    [No Abstract]   [Full Text] [Related]  

  • 47. [Digestive involvement of scleroderma].
    Ponge T; Bruley des Varannes S
    Rev Prat; 2002 Nov; 52(17):1896-900. PubMed ID: 12532866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of the function of the tubular esophagus in patients with progressive systemic scleroderma based on a standardized symptom score].
    Köhler H; Adamek RJ
    Dtsch Med Wochenschr; 1998 Feb; 123(8):212-6. PubMed ID: 9526490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Digestive manifestations during systemic scleroderma].
    Gane S; Boicescu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):515-20. PubMed ID: 2577013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Involvement of the small intestine in systemic scleroderma].
    Marie I; Lévesque H; Ducrotté P; Courtois H
    Rev Med Interne; 1999 Jun; 20(6):504-13. PubMed ID: 10422142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrointestinal motility disorders in scleroderma.
    Sjogren RW
    Arthritis Rheum; 1994 Sep; 37(9):1265-82. PubMed ID: 7945489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Visceral scleroderma].
    Chomette G; Tranbaloc P; Beaufils H; Auriol M
    Ann Med Interne (Paris); 1984; 135(8):606-10. PubMed ID: 6529056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Digestive localizations of scleroderma and malabsorption].
    Le Parco JC; Chemaly A; Bader JP; Martin E; Lambling A
    Sem Hop; 1972 Jun; 48(28):2057-67. PubMed ID: 4343442
    [No Abstract]   [Full Text] [Related]  

  • 54. [Is an esophageal transit scintigram necessary in patients with gastroesophageal reflux?].
    Tăranu D; Oproiu C; Aposteanu G; Jovin G; Murgoci P; Timiş E; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):369-76. PubMed ID: 2573947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Saliva transit in patients with gastroesophageal reflux disease.
    Cassiani RA; Mota GA; Aprile LR; Dantas RO
    Dis Esophagus; 2015 Oct; 28(7):673-7. PubMed ID: 25082357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis.
    Maddern GJ; Horowitz M; Jamieson GG; Chatterton BE; Collins PJ; Roberts-Thomson P
    Gastroenterology; 1984 Oct; 87(4):922-6. PubMed ID: 6468880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinico-manometric correlation in esophageal involvement of progressive systemic sclerosis].
    Corti RE; Outeda JL; Naveiro JJ; Nicolino D; Corti RN; Crosetti E
    Acta Gastroenterol Latinoam; 1982; 12(1):1-9. PubMed ID: 7136451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Correlation between the radiologic study of deglutition and the clinical picture in systemic sclerosis (scleroderma)].
    Montesi A; Pesaresi A; Cavalli ML; Serri L; Salmistraro D; Candela M; Gabrielli A
    Radiol Med; 1990 Sep; 80(3):296-300. PubMed ID: 2236689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.